Dr Bradley Wong
MBBS, FRANZCR, Radiation Oncologist
I believe modern technology, evidence-based care, and a holistic approach may offer the best possible outcomes for patients and their families.
Clinical interests in skin cancer, prostate cancer, urological cancers, breast cancer, palliative care, and benign conditions.
Brad completed a Bachelor of Medicine and Surgery (MBBS) at the University of Adelaide before undertaking his radiation oncology training in South Australia. In 2015 he was awarded Fellowship to the Royal Australian and New Zealand College of Radiologists (FRANZCR). He currently practices as a consultant radiation oncology specialist with GenesisCare in Buderim, Nambour, Bundaberg and Hervey Bay with outreach clinics in Gympie and Noosa.
Brad is dedicated to offering personalised care through the provision of modern treatment techniques including volumetric modulated arc therapy (VMAT) and image guided radiation therapy (IGRT). In recent years Brad has presented at a number of medical conferences on the topics of skin cancer and prostate cancer. He regularly participates in multidisciplinary team meetings and believes in a holistic approach to patient care.
Brad has been involved in clinical teaching and has been awarded the academic title of Senior Lecturer at the University of Queensland School of Medicine. As well as supervising medical student tutorials, he is also a clinical examiner at the University of Queensland. He currently serves on the GenesisCare National Skin Cancer Tumour Reference Group (TRG) and has previously served as the chairman of the Wide Bay Urology MDT.
Brad works across many tumour types, and has clinical interests in the management of skin cancer, prostate cancer, urological cancers, breast cancer, plus benign conditions and palliative care. His current major technical interests are in the use of 3D printed bolus for wide field skin treatments.
Medical conference presentations
- Multidisciplinary Management of Challenging Skin Cancer Cases using Modern Radiation Therapy Techniques Skin Cancer College Australasia, Symposium, 2020
- Modern Radiotherapy for Non-Melanomatous Skin Cancer Australasian Skin Cancer Congress, Gold Coast, 2019
- Hypofractionation in Prostate Cancer GenesisCare Education Symposium, Brisbane, 2019
- Radiotherapy in Regional Regions – The Bundaberg Experience GenesisCare Experience, Sydney, 2018
- Senior Lecturer, School of Medicine, University of Queensland
- Clinical Examiner, School of Medicine, University of Queensland, Rural Clinical School, Bundaberg
- Fellowship of the Royal Australian and New Zealand College of Radiologists (FRANZCR)
- Skin cancer treatments and modern technology including 3D printed bolus, benign conditions, and prostate cancer.
- GenesisCare National Skin Cancer Tumour Reference Group (TRG)
- Royal Australian & New Zealand College of Radiologists (RANZCR)
- Urological Society of Australia and New Zealand (USANZ)
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
- American Society for Radiation Oncology (ASTRO)
- Volumetric modulated arc therapy (VMAT) for extensive skin field cancerisation (ESFC) – exploring the limits of treatment volumes with a case series of backs: International Journal of Radiology & Radiation Therapy, 2020
- A technique for treating extended skin field cancerisation using volumetric modulated arc therapy: International Journal of Radiology & Radiation Therapy, 2019
- Wide Field Radiotherapy using 3D Printed Bolus for Management of Field Cancerisation of the Skin: Doctor Magazine, Editorial, 2019
- Glomus Jugulare Tumours: A fifteen year radiotherapy experience in South Australia: Journal of Clinical Neuroscience, 2014
- Fogarty GB, Christie DRH, Wong B, et al. Experiences in growing a skin radiation therapy practice. Int J Radiol Radiat Ther. 2020;7(6):168‒182. DOI: 10.15406/ijrrt.2020.07.00285
- Andrew E. P., David C, Bradley W, Peter O’B., et al. & on behalf of the National Dermatology Radiation Oncology Registry (NDROR) investigators and sites (2022) ‘Preliminary efficacy and safety analysis: 12-month results in 83 patients using a novel approach of widefield radiation therapy for extensive skin field cancerization with or without keratinocyte cancers’